Breaking Down Guizhou Chanhen Chemical Corporation Financial Health: Key Insights for Investors

Investors eyeing Guizhou Chanhen Chemical (002895.SZ) will want to dig into a financial picture that combines rapid top-line expansion and solid profitability - the company posted a trailing twelve months revenue of CNY 7.74 billion (up 48.17% YoY), with Q3 2025 revenue at CNY 2.44 billion (+64.09% YoY) and revenue per employee of CNY 2.30 million; 2024 net income reached CNY 956 million with a net margin near 16.2% and ROE of 16.93%, while operating cash flow of CNY 859 million covered CNY 452 million in capex and cash on hand stood at CNY 1.98 billion - balanced against a conservative debt profile (long-term debt CNY 1.28 billion, debt-to-equity 0.36) and liquidity metrics (current ratio 1.09, quick ratio 0.77); valuation multiples show a market cap around CNY 21.30 billion, EV CNY 23.71 billion, trailing P/E 15.87 and EV/EBITDA 11.5, with analysts targeting CNY 40.99 - the following analysis breaks down revenue drivers, margin expansion, leverage, liquidity, valuation and the key operational and regulatory risks shaping the stock's outlook

Guizhou Chanhen Chemical Corporation (002895.SZ) - Revenue Analysis

Guizhou Chanhen Chemical Corporation (002895.SZ) has demonstrated strong top-line momentum across 2024-2025, driven by volume gains and price realization in its chemical product lines. Key figures highlight rapid growth and improving revenue productivity per employee as the company scales.

• 2024 annual revenue: CNY 5.91 billion (up 36.72% vs. 2023: CNY 4.32 billion).
• TTM revenue (ending Sep 30, 2025): CNY 7.74 billion (YoY growth 48.17%).
• Q3 2025 revenue: CNY 2.44 billion (up 64.09% vs. Q3 2024).
• Revenue per employee: CNY 2.30 million (3,365 employees).
• Market capitalization: ~CNY 21.30 billion; P/S ratio: 3.05.
• Enterprise value: CNY 23.71 billion; EV/Revenue multiple: 3.06x.

Investors should note the pace of revenue expansion relative to valuation multiples: the company's ~3.06x EV/Revenue and 3.05x P/S reflect expectations of continued top-line acceleration. For background on corporate strategy and how the business generates revenue, see Guizhou Chanhen Chemical Corporation: History, Ownership, Mission, How It Works & Makes Money.

Guizhou Chanhen Chemical Corporation (002895.SZ) - Profitability Metrics

• Net income (2024): CNY 956 million - up 24.80% from CNY 765 million in 2023.
• Net profit margin (2024): ~16.2%, reflecting effective cost management and margin expansion.
• Diluted EPS (2024): CNY 1.70; trailing P/E: 15.87.
• Return on equity (ROE, 2024): 16.93% - indicating efficient use of shareholders' equity.
• Operating cash flow (2024): CNY 859 million, which comfortably covers capex of CNY 452 million.
• Gross profit (2024): CNY 2.14 billion, up from CNY 1.64 billion in 2023 - gross margin improvement signaled.

• Cash conversion: Operating cash flow covers capex ~1.90x (859 / 452), indicating solid free-cash generation after reinvestment.
• Margin drivers: improved gross profit (+CNY 500 million year-on-year) implies better input cost management or price realization.
• Valuation context: P/E of 15.87 on EPS CNY 1.70 provides a straightforward multiple for relative valuation versus peers.

Guizhou Chanhen Chemical Corporation (002895.SZ) - Debt vs. Equity Structure

• Long-term debt and capital lease obligations: CNY 1.28 billion (June 2025).
• Total debt increase over three years: +CNY 504.75 million, indicating gradual leverage growth.
• Debt-to-equity ratio: 0.36 - conservative relative to many industrial peers.
• Interest coverage ratio: 15.87 - strong ability to service interest from operating earnings.
• Cash and cash equivalents: CNY 1.98 billion - provides a substantial short-term buffer versus debt.
• Total assets: CNY 13.36 billion; long-term debt-to-assets ratio: 0.10.

• The 0.36 debt-to-equity ratio and 15.87 interest coverage suggest low refinancing risk under current operating profit levels.
• Cash of CNY 1.98 billion nearly offsets long-term debt of CNY 1.28 billion, improving net-debt dynamics and flexibility.
• The CNY 504.75 million rise in total debt over three years warrants monitoring if capex or acquisitions drive further increases.
• At a long-term debt-to-assets ratio of 0.10, the balance sheet remains asset-heavy, supporting creditor comfort and potential borrowing capacity.

Guizhou Chanhen Chemical Corporation (002895.SZ) - Liquidity and Solvency

• Current ratio: 1.09 - indicates adequate short‑term liquidity to cover current liabilities with current assets.
• Quick ratio: 0.77 - signals potential difficulty meeting immediate obligations without relying on inventory liquidation.
• Cash and cash equivalents: CNY 1.98 billion - a meaningful buffer to absorb short‑term shocks or fund working capital needs.
• Operating cash flow (2024): CNY 859 million - positive operational cash generation supporting ongoing liquidity.
• Interest coverage ratio: 15.87 - strong ability to service interest expenses from operating earnings.
• Total debt‑to‑assets ratio: 0.25 - moderate leverage, suggesting balanced use of debt financing relative to asset base.

Guizhou Chanhen Chemical Corporation (002895.SZ) - Valuation Analysis

• Trailing P/E: 15.87 - reflects current earnings multiple based on reported trailing twelve months profit.
• Forward P/E: 15.20 - implies analysts expect stable or slightly improving earnings over the next 12 months.
• P/S: 3.05 - indicates the market is valuing about three times the company's annual sales.
• P/B: 2.51 - suggests investors pay roughly 2.5x book value, typical for asset-heavy chemical firms with steady returns.
• EV/EBITDA: 11.50 - a mid-range multiple that balances earnings power against enterprise value, signaling neither deep discount nor premium.
• Market Capitalization: CNY 21.18 billion; Enterprise Value: CNY 23.71 billion - modest leverage implied by EV close to market cap.
• Analyst 12-month Price Target: CNY 40.99 (range CNY 39.97-42.00) - consensus band showing tight analyst agreement.
• Beta: 0.57 - lower volatility relative to the broader market, attractive for risk-averse investors.

Guizhou Chanhen Chemical Corporation (002895.SZ) - Risk Factors

• Regulatory and environmental compliance risk: China's tightening of environmental and safety standards can force production curtailments, higher compliance capital expenditure, fines, or license suspensions.
• Market and competitive pressure: Intense domestic and international competition in phosphate chemicals may compress margins and erode market share.
• Raw material and commodity price volatility: Fluctuations in phosphate rock, sulfur, and coal prices, plus freight and logistics costs, can swing margins significantly.
• Currency and export risk: Exposure to FX movements and trade policy may impact export revenue and repatriated profitability.
• Resource and supply chain risk: Dependence on phosphate mining and third-party suppliers creates vulnerability to mine closures, reserve depletion, or logistics disruptions.
• Operational incident risk: Environmental incidents, safety accidents, or regulatory changes can reduce utilization and require large remediation charges.
• Leverage and liquidity risk: Existing debt levels and refinancing needs may constrain flexibility if cash flow weakens.

• Compliance-driven capital needs: Recent environmental enforcement trends in China suggest rising annualized compliance CapEx; a 10-20% increase in annual CapEx would pressure free cash flow and may necessitate incremental financing.
• Input-cost passthrough limitations: If phosphate rock or sulfur prices spike by 30% (histor intra-year swings), the ability to pass costs to customers is constrained by competitive pricing, reducing gross margin by an estimated 6-8 percentage points in stressed scenarios.
• FX and export exposure: A 5-10% RMB appreciation versus major trading currencies can meaningfully reduce export competitiveness and reported RMB revenue from overseas sales.
• Supply disruption scenarios: Mine closure or logistic interruption reducing feedstock availability by 20% could lower utilization and EBITDA by an estimated 25-35% until alternate sourcing is secured.
• Debt-servicing sensitivity: At current net debt / EBITDA ~2.1x, a 30% EBITDA decline would push leverage above 3x, increasing refinancing risk and interest expense burden.

• Track environmental and safety CapEx guidance and actual spend to gauge regulatory risk management.
• Monitor phosphate rock spot and contract prices, plus inventory days, to assess margin pressure.
• Watch leverage ratios (net debt/EBITDA, interest coverage) and upcoming debt maturities for refinancing risk.
• Review reserve replacement and mining permit updates to confirm long-term feedstock security.
• Follow trade policy and FX movements affecting export revenue and pricing power.

Guizhou Chanhen Chemical Corporation (002895.SZ) - Growth Opportunities

• Product portfolio upgrade: prioritized development of high-purity phosphates and specialty phosphate derivatives for semiconductor, lithium-ion battery precursor (electrolyte additives) and electronics-grade chemistries.
• Capacity expansion: announced phased increases in production capacity to support both agricultural-grade and higher-margin industrial grades.
• Market diversification: pursuing strategic partnerships and joint ventures to access downstream OEMs in electronics and new energy segments.
• R&D focus: allocating budget to pilot-scale production of novel phosphate formulations and process optimization to lower unit costs.
• Policy advantage: benefiting from Chinese industrial policy encouraging supply chain localization and cleaner chemical production practices.

• Revenue levers: conversion of commodity sales to specialty products (higher ASPs), margin uplift from scale and process improvements, and new contracts from downstream electronics/new energy manufacturers.
• Customer segmentation opportunities: large-scale agricultural distributors, industrial chemical processors, and electronics/materials OEMs requiring high-purity inputs.
• Deal catalysts: JVs with regional producers to secure feedstock, off-take agreements with battery or semiconductor supply chains, and government-supported project financing.